ExoFlo Exosomes are one of the most exiting therapy tools in regenerative medicine today. Exosomes have been used by clinicians in wound care, burns, pain and aesthetic applications including post laser/post micro needling and hair loss therapy.
Aesthetic Applications
Chronic Non-Healing Wounds
Soft Tissue Injuries
Chronic Inflamed Joint Pain
Repetitive Motion Injuries
Inflammation
Exosomes are cell-derived vesicles that are present in many eukaryotic fluids, including blood, urine, and cultured medium of cell cultures. They are packaged inside cellular endosomes and secreted from the cell, and they are responsible for direct cell to cell communication. Exosomes are regarded as the purest form of cellular signaling available because their function is to direct tissue and wound healing by activating cell responses.
Exosomes induce changes in nearby cells that create the appropriate healing environment and aid in tissue repair.
As the technology and discovery of new methods of treating patients has evolved, scientific evidence shows that the optimal way to provide true regenerative therapy is to directly provide the signals as its own therapy and avoid potential issues with delivering and keeping transplanted cells alive.
Although not specifically FDA approved for hair loss, exosomes have shown amazing clinical results for treating hair loss from physicians around the world.
Dr. Daniel McGrath is one of the first and most experienced hair loss specialists in the world to be working with Exosomes and has even benefited from the therapy himself.
Dr. Daniel McGrath is the current President of the American Board of Hair Restoration Surgery (ABHRS), the only certification program recognized by the International Society of Hair Restoration Surgery (ISHRS). He is one of less than 200 hair replacement surgeons around the world to have achieved this level of expertise in hair restoration surgery.
Dr. McGrath has received the Fellow designation by the International Society of Hair Restoration Surgery, a designation only given to 130 hair transplant surgeon worldwide – he performed his General Surgery Residency at Botsford General Hospital before entering into private practice.
Suffering from male pattern hair loss since his mid twenties Dr. McGrath underwent hair restoration surgery and was so impressed with the results and current techniques that he began a year long Hair Transplantation Fellowship under the tutelage of some of the worlds leading surgeons. Less than 20 hair surgeons worldwide have dedicated the time and energy to refine their skills through a fellowship program.
Today, Dr. McGrath has dedicated his practice to hair restoration for both men and women. Dr. McGrath performs FUE, FUT hair transplant surgery and is a pioneer in medical therapy, Laser Therapy and FDA approved oral and topical medications.
Dr. Ziering has performed 25,000 procedures and still counting! He serves on the faculty of the ISHRS World Congress with over 20 years of tenure and is a past Chairman of the Advanced Board Review Course. In 2018, Dr. Z served as the Chairman of Workshops for the ISHRS World Congress.
As a faculty member of the ISHRS Live Surgery Workshop, he maintains membership for ISHRS Fellowship Training and CME committees as well. In 2019, Dr. Ziering served as faculty for the FUE European Live Surgery Conference. Most notably, he was on the founding board of the American Board of Hair Restoration Surgeons (ABHRS) which is internationally recognized as the only governing board for hair restoration surgery certification for physicians worldwide.
Further, he was invited to be part of the founding faculty of the 2020 Global Hair Loss Summit of 2020 which brings together the very best and brightest doctors in the field of surgical hair restoration.
This is a new frontier in regenerative therapies for hair restoration. ExoFlo Exosomes have been recently discovered to be involved in direct cell signaling. ExoFlo™ exosomes are isolated from human bone marrow mesenchymal stromal cells (MSCs). They are purified using proprietary cGMP processing and are sterile filtered and tested per USP<71> sterility testing. The unique benefit Exoflow exosomes is they provide a wide array of regulatory proteins to stimulate and modulate many processes within the normal healing cascade. They unlock the healing potential within a patient’s own cells with an emphasis on reducing chronic inflammation and promoting regeneration of hair follicles that have previously ceased growing.
One of our highly skilled Registered Nurses will inject the balding areas with 5ml or more of ExoFlo Exosomes. New hair typically begins to grow up to 6 months after initial treatment.
The patient will not experience any discomfort. Less than 10% of patients have reported developing a mild fever, headache, nausea or vomiting. However, these side effects have never lasted more than three days and usually resolve within 24 hours. No long-term negative side effects have been reported.
Exosome therapy may begin promoting natural hair growth in as little as two to three months. New hair growth can continue over the course of a year, with the most noticeable results usually being seen six months after treatment has been administered.
DISCLAIMER: Regenerative therapies such as Exosome Therapy we provide is not an FDA approved treatment for any condition or disease and considered experimental. In complying with the law, we are not able to imply or claim that Exosome Therapy is able to benefit, reverse, or cure any specific disease or degenerative condition. We simply provide Exosome Therapy as an “autologous”, same day procedure, without stimulation or culturing. We hope that, combined with other therapies recommended by your doctor, Exosome Therapy may improve quality of life. All information on this website including reference to current research journals and numerous published studies are simply for educational purposes only.
